Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06632158 · ClinicalTrials.gov registry record · Phase 2

Personal Relevance of Psychotherapy for Asian Americans

A Phase 2 study of Anxiety and Stress, sponsored by IRIS Media.

Completed
Registry status
Phase 2
Development phase
268
Enrollment target
1
Study location

NCT06632158 is a Phase 2 study of Anxiety and Stress that has completed, run by IRIS Media. The registered enrollment target is 268 participants, below the 439-participant average among 364 other Anxiety trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06632158, a Phase 2 study of Anxiety and Stress, has completed, sponsored by IRIS Media.

COMPLETED
Registry status
Phase 2
Development phase
268 participants
Enrollment target
1
Study location

Study Summary

Using a three-armed design the investigators will test whether participants in the Mindboba online application experience significantly greater improvements as compared to participants in the active control (online app based on Cognitive Behavioral Therapy) and participants in the business-as-usual control. The outcome measures are self-reported social problem-solving, self-efficacy, stress, depression, anxiety, attitudes towards seeking mental health, and knowledge.

Interventions

  • BEHAVIORAL MindBoba
  • BEHAVIORAL Mindshift CBT

Study Locations (1)

Oregon

  • IrisEd dba Trifoia - Eugene

Trial Details

FieldValue
Enrollment Target 268 participants
Start Date 2024-05-01
Est. Completion 2024-12-30
Phase Phase 2

Sponsor

IRIS Media

3 total trials

What the Registry Record Tells You About NCT06632158

The ClinicalTrials.gov registry entry for NCT06632158 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 364 other Anxiety trials with a reported enrollment target (39% lower). The listed sponsor is IRIS Media, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which MindBoba is the first listed.

NCT06632158 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT06632158 about?

NCT06632158 is a clinical study titled "Personal Relevance of Psychotherapy for Asian Americans". Using a three-armed design the investigators will test whether participants in the Mindboba online application experience significantly greater improvements as compared to participants in the active control (online app based on Cognitive Behavioral Therapy) and participants in the business-as-usual ...

What is the current status of trial NCT06632158?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 268 participants. The study started on 2024-05-01. Estimated completion is 2024-12-30.

What conditions does trial NCT06632158 study?

This clinical trial studies the following conditions: Anxiety, Stress, Behavior.

What interventions are being tested in trial NCT06632158?

The interventions under investigation include: MindBoba (BEHAVIORAL), Mindshift CBT (BEHAVIORAL).

Who is sponsoring clinical trial NCT06632158?

This trial is sponsored by IRIS Media, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06632158 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.